<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Six patients with necrotizing <z:hpo ids='HP_0002633'>vasculitis</z:hpo> were treated with oral <z:chebi fb="0" ids="23359">colchicine</z:chebi> as part of an open study </plain></SENT>
<SENT sid="1" pm="."><plain>Four patients with cutaneous <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> levels of serum complement and one patient with <z:hpo ids='HP_0002633'>vasculitis</z:hpo> associated with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e> demonstrated clinical improvement while receiving <z:chebi fb="0" ids="23359">colchicine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>One patient with <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo>, hypocomplementemia, and cutaneous <z:hpo ids='HP_0002633'>vasculitis</z:hpo> showed no response to <z:chebi fb="0" ids="23359">colchicine</z:chebi> therapy </plain></SENT>
<SENT sid="3" pm="."><plain>In three patients, clinical improvement persisted after its withdrawal </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="23359">Colchicine</z:chebi> may be effective in controlling cutaneous necrotizing <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e> through its effect on polymorphnuclear leukocyte function </plain></SENT>
</text></document>